Deciphera to be acquired by Ono Pharmaceutical for $2.4 billion
The Boston Globe - 2024-04-29T13:35:02.992Z

Ono Pharmaceutical will pay $25.60 per Deciphera share in cash, a premium of nearly 75 percent on the Waltham cancer biotech’s closing price of $14.65 on Friday. Read this story